Company Overview

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

  • Name

    The Cigna Group

  • CEO

    Mr. David Michael Cordani

  • Website

    www.cigna.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1792

Profile

  • Market Cap

    $99.87B

  • EV

    $125.88B

  • Shares Out

    279.55M

  • Revenue

    $216.01B

  • Employees

    71,413

Margins

  • Gross

    11.12%

  • EBITDA

    4.34%

  • Operating

    3.51%

  • Pre-Tax

    1.9%

  • Net

    1.72%

  • FCF

    3.69%

Returns (5Yr Avg)

  • ROA

    3.93%

  • ROTA

    91.7%

  • ROE

    13.14%

  • ROCE

    7.56%

  • ROIC

    5.4%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $398.29

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $6,788M

  • Net Debt

    $25.82B

  • Debt/Equity

    0.79

  • EBIT/Interest

    5.23

Growth (CAGR)

  • Rev 3Yr

    8.95%

  • Rev 5Yr

    16.08%

  • Rev 10Yr

    20.52%

  • Dil EPS 3Yr

    -17.75%

  • Dil EPS 5Yr

    1.89%

  • Dil EPS 10Yr

    5.74%

  • Rev Fwd 2Yr

    12.43%

  • EBITDA Fwd 2Yr

    10.3%

  • EPS Fwd 2Yr

    12.74%

  • EPS LT Growth Est

    11.35%

Dividends

  • Yield

  • Payout

    40.89%

  • DPS

    $5.26

  • DPS Growth 3Yr

    38.03%

  • DPS Growth 5Yr

    165.33%

  • DPS Growth 10Yr

    62.89%

  • DPS Growth Fwd 2Yr

    10.2%

NYSE:CI